In addition, overexpression
of miR-1246 has been found in several types of cancers
such as liver cancer, pancreatic cancer, and colorectal carcinoma
[13,15,16]. However, data on the expression of miR-1246 in
OSCC and its clinical impact on patient survival remain scarce